Skip to main content

Table 2 Health status and behaviour variables (N = 300)

From: Non-adherence to anti-retroviral therapy among HIV infected adults in Mon State of Myanmar

Variables Number Percent
Duration on ART Mean ± SD: 4.3 ± 2.1
  < 1 year 25 8.3
 1-3 year 147 49.0
  > 3 year 128 42.7
Recent CD4 (cells/mm3) Mean ± SD: 517.5 ± 263.3
  < 500 158 52.7
 500-1000 122 40.7
  > 1000 20 6.7
HIV medication
 ART first line drugs 277 92.3
 ART second line drugs 23 7.7
ART Regimen
 TDF/ABC + 3TC + EFV (one time/day) 171 57.0
 AZT/ABC + 3TC + NVP/LPV/r (2 times/day) 129 43.0
Co-morbid diseases
 Absence of co-morbidity 248 82.7
 Presence of co-morbidity 52 17.3
 Past month alcohol use 50 16.7
 Smokes tobacco daily 27 9.0
 Smokeless tobacco use daily 37 12.3
 Disclosure of HIV status to others 241 80.3
 Moderate to severe depressive symptoms 23 7.7
Internalized stigma (Range:0-7) Mean ± SD 2.7 ± 2.3
 No stigmatization 67 22.3
 Low stigmatization 132 44.0
 High stigmatization 101 33.7
Social support (Range 3-12) Mean ± SD 9.7 ± 2.0
 Less 194 64.7
 High 106 35.3
Sex functioning among male respondent (n = 107) (Range 5-25) Mean ± SD: 18.9 ± 2.7
 No erectile dysfunction (ED) 49 45.8
 Mild ED 44 41.1
 Mild to moderate ED 14 13.1
  1. TDF Tenofovir, ABC Abacavir, 3TC Lamivudine, EFV Efavirenz, AZT Zidovudine, NVP Nevirapine, LPV/r Lopinavir/ritonavir, SD standard deviation